Effects of β-Glucans on Pro-Inflammatory Markers and Behavioral Phenotype in a Valproic Acid (VPA)-Induced Autism Model in Zebrafish
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209243 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Diletta Camussi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology and Molecular Medicine Unit, IRCCS Stella Maris Foundation, 56128 Pisa, Italy. Hauptthemen laut MEDLINE: Valproic Acid, beta-Glucans, Behavior, Animal, Autistic Disorder. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Animal Care and Use Committee of the IRCCS Stella Maris Foundation, European Union.
Abstract (Originalsprache)
Autism Spectrum Disorder (ASD) is a multifactorial neurodevelopmental condition in which neuroinflammation, oxidative stress, and synaptic dysfunction act as converging mechanisms. Prenatal exposure to valproic acid (VPA), an antiepileptic drug and histone deacetylase inhibitor, is a recognized environmental risk factor associated with ASD-like phenotypes. Zebrafish, with conserved neuroimmune pathways, rapid development, and quantifiable social behavior, represents a robust model for investigating ASD pathophysiology and testing therapeutic candidates. This study aimed to assess if a previously selected concentration of VPA is capable of inducing persistent alterations from early development through adulthood, and to assess the potential of β-glucans, natural polysaccharides with antioxidant and immunomodulatory properties, to mitigate VPA-induced alterations. A multimodal approach included morphological evaluation, mitochondrial respiration, quantitative PCR of inflammatory markers, and behavioral assays targeting locomotion, anxiety-like responses, and social preference. Low-dose VPA (25 μM) induced developmental and behavioral difficulties, accompanied by a transient reduction in mitochondrial respiratory capacity. β-glucan supplementation attenuated selected VPA-induced alterations, including inflammatory gene-expression changes in larvae and behavioral alterations in adulthood. Overall, these findings provide preclinical evidence that β-glucans can modulate selected VPA-induced inflammatory, molecular and behavioral alterations and support further investigation of their potential effects in neurodevelopmental models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurobiology and Molecular Medicine Unit, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
- Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
- Department of Veterinary Sciences, University of Pisa, 56126 Pisa, Italy.
- IRCCS Neuromed, 86077 Pozzilli, Italy.
ORCID-Profile: Maria Marchese, Baldassare Fronte, Filippo Maria Santorelli, Serena Mero
Förderung
- Ministero della Salute
- Animal Care and Use Committee of the IRCCS Stella Maris Foundation
- European Union
Zitieren
APA
Camussi, D., Marchese, M., Ogi, A., Fronte, B., Nicoletti, F., Santorelli, F. M., & Mero, S. (2026). Effects of β-Glucans on Pro-Inflammatory Markers and Behavioral Phenotype in a Valproic Acid (VPA)-Induced Autism Model in Zebrafish. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209243
Vancouver
Camussi D, Marchese M, Ogi A, Fronte B, Nicoletti F, Santorelli FM, et al. Effects of β-Glucans on Pro-Inflammatory Markers and Behavioral Phenotype in a Valproic Acid (VPA)-Induced Autism Model in Zebrafish. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209243
BibTeX
@article{Camussi2026,
author = {Camussi, Diletta and Marchese, Maria and Ogi, Asahi and Fronte, Baldassare and Nicoletti, Ferdinando and Santorelli, Filippo Maria and Mero, Serena},
title = {Effects of β-Glucans on Pro-Inflammatory Markers and Behavioral Phenotype in a Valproic Acid (VPA)-Induced Autism Model in Zebrafish},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209243}
}
EUVIMED